U
Fuse Medical, Inc.
FZMD
$0.0899
-$0.01-10.01%
D
Sell
8/30/2024Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to D from D+ on 8/30/2024 due to a decline in the total return index.
Fuse Medical, Inc. (FZMD) was downgraded to D from D+ on 8/30/2024 due to a decline in the total return index.
D
Sell
8/15/2024Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D+ from D on 8/15/2024 due to an increase in the volatility index.
Fuse Medical, Inc. (FZMD) was upgraded to D+ from D on 8/15/2024 due to an increase in the volatility index.
D
Sell
7/29/2024Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to D from D+ on 7/29/2024 due to a large decline in the total return index.
Fuse Medical, Inc. (FZMD) was downgraded to D from D+ on 7/29/2024 due to a large decline in the total return index.
D
Sell
7/1/2024Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to D+ from C- on 7/1/2024 due to a decline in the volatility index and total return index.
Fuse Medical, Inc. (FZMD) was downgraded to D+ from C- on 7/1/2024 due to a decline in the volatility index and total return index.
C
Hold
6/12/2024Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to C- from D+ on 6/12/2024 due to an increase in the volatility index and total return index.
Fuse Medical, Inc. (FZMD) was upgraded to C- from D+ on 6/12/2024 due to an increase in the volatility index and total return index.
D
Sell
5/23/2024Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to D+ from C- on 5/23/2024 due to a decline in the volatility index.
Fuse Medical, Inc. (FZMD) was downgraded to D+ from C- on 5/23/2024 due to a decline in the volatility index.
C
Hold
5/7/2024Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to C- from D+ on 5/7/2024 due to an increase in the total return index, solvency index and valuation index.
Fuse Medical, Inc. (FZMD) was upgraded to C- from D+ on 5/7/2024 due to an increase in the total return index, solvency index and valuation index.
D
Sell
3/28/2024Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to D+ from C- on 3/28/2024 due to a decline in the solvency index and valuation index.
Fuse Medical, Inc. (FZMD) was downgraded to D+ from C- on 3/28/2024 due to a decline in the solvency index and valuation index.
C
Hold
3/11/2024Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to C- from D+ on 3/11/2024 due to an increase in the total return index and volatility index.
Fuse Medical, Inc. (FZMD) was upgraded to C- from D+ on 3/11/2024 due to an increase in the total return index and volatility index.
D
Sell
2/23/2024Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to D+ from C- on 2/23/2024 due to a noticeable decline in the total return index and efficiency index.
Fuse Medical, Inc. (FZMD) was downgraded to D+ from C- on 2/23/2024 due to a noticeable decline in the total return index and efficiency index.
C
Hold
12/5/2023Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to C- from C on 12/5/2023 due to a substantial decline in the total return index.
Fuse Medical, Inc. (FZMD) was downgraded to C- from C on 12/5/2023 due to a substantial decline in the total return index.
C
Hold
11/17/2023Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to C from C- on 11/17/2023 due to a significant increase in the total return index, volatility index and valuation index.
Fuse Medical, Inc. (FZMD) was upgraded to C from C- on 11/17/2023 due to a significant increase in the total return index, volatility index and valuation index.
C
Hold
8/22/2023Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to C- from D+ on 8/22/2023 due to an increase in the total return index.
Fuse Medical, Inc. (FZMD) was upgraded to C- from D+ on 8/22/2023 due to an increase in the total return index.
D
Sell
8/15/2023Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D+ from D on 8/15/2023 due to a significant increase in the growth index, volatility index and total return index. EBIT increased 322.77% from -$165.6 to $368.9, earnings per share increased from -$0.0032 to $0.0039, and total revenue increased 25.42% from $3.98M to $5M.
Fuse Medical, Inc. (FZMD) was upgraded to D+ from D on 8/15/2023 due to a significant increase in the growth index, volatility index and total return index. EBIT increased 322.77% from -$165.6 to $368.9, earnings per share increased from -$0.0032 to $0.0039, and total revenue increased 25.42% from $3.98M to $5M.
D
Sell
5/2/2023Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to D from D+ on 5/2/2023 due to a decline in the volatility index, total return index and efficiency index.
Fuse Medical, Inc. (FZMD) was downgraded to D from D+ on 5/2/2023 due to a decline in the volatility index, total return index and efficiency index.
D
Sell
4/17/2023Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D+ from E+ on 4/17/2023 due to a significant increase in the valuation index, efficiency index and solvency index. Net income increased 37,962.77% from -$9.4 to $3.56M, debt to equity declined from -0.62 to -7.55, and total capital increased 237.86% from -$1.48M to $2.04M.
Fuse Medical, Inc. (FZMD) was upgraded to D+ from E+ on 4/17/2023 due to a significant increase in the valuation index, efficiency index and solvency index. Net income increased 37,962.77% from -$9.4 to $3.56M, debt to equity declined from -0.62 to -7.55, and total capital increased 237.86% from -$1.48M to $2.04M.
E
Sell
3/14/2023Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to E+ from D on 3/14/2023 due to a decline in the total return index and volatility index.
Fuse Medical, Inc. (FZMD) was downgraded to E+ from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/9/2023Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D from E+ on 02/09/2023.
Fuse Medical, Inc. (FZMD) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to E+ from D on 2/8/2023 due to a noticeable decline in the total return index, solvency index and valuation index. The quick ratio declined from 0.32 to 0.27, and debt to equity increased from -0.67 to -0.62.
Fuse Medical, Inc. (FZMD) was downgraded to E+ from D on 2/8/2023 due to a noticeable decline in the total return index, solvency index and valuation index. The quick ratio declined from 0.32 to 0.27, and debt to equity increased from -0.67 to -0.62.
D
Sell
5/16/2022Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index and total return index.
Fuse Medical, Inc. (FZMD) was upgraded to D from E+ on 5/16/2022 due to an increase in the valuation index and total return index.
E
Sell
5/13/2022Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to E+ from D on 05/13/2022.
Fuse Medical, Inc. (FZMD) was downgraded to E+ from D on 05/13/2022.
D
Sell
5/4/2022Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index and valuation index.
Fuse Medical, Inc. (FZMD) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index and valuation index.
E
Sell
5/1/2022Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to E+ from D on 05/01/2022.
Fuse Medical, Inc. (FZMD) was downgraded to E+ from D on 05/01/2022.
D
Sell
4/21/2022Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D from E+ on 04/21/2022.
Fuse Medical, Inc. (FZMD) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to E+ from D on 4/20/2022 due to a substantial decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.5 to 0.41.
Fuse Medical, Inc. (FZMD) was downgraded to E+ from D on 4/20/2022 due to a substantial decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.5 to 0.41.
D
Sell
11/11/2021Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D from D- on 11/11/2021 due to a major increase in the solvency index, valuation index and total return index.
Fuse Medical, Inc. (FZMD) was upgraded to D from D- on 11/11/2021 due to a major increase in the solvency index, valuation index and total return index.
D
Sell
11/8/2021Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index and solvency index. Debt to equity increased from -0.8 to -0.57, and the quick ratio declined from 0.64 to 0.54.
Fuse Medical, Inc. (FZMD) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index and solvency index. Debt to equity increased from -0.8 to -0.57, and the quick ratio declined from 0.64 to 0.54.
D
Sell
4/1/2021Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to D from D+ on 4/1/2021 due to a substantial decline in the efficiency index, growth index and solvency index. Operating cash flow declined 153.7% from $421.6 to -$226.4.
Fuse Medical, Inc. (FZMD) was downgraded to D from D+ on 4/1/2021 due to a substantial decline in the efficiency index, growth index and solvency index. Operating cash flow declined 153.7% from $421.6 to -$226.4.
D
Sell
3/26/2021Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D+ from D on 3/26/2021 due to an increase in the total return index, volatility index and solvency index.
Fuse Medical, Inc. (FZMD) was upgraded to D+ from D on 3/26/2021 due to an increase in the total return index, volatility index and solvency index.
D
Sell
11/18/2020Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D from D- on 11/18/2020 due to a significant increase in the growth index, efficiency index and solvency index. Operating cash flow increased 258.5% from $117.6 to $421.6, EBIT increased 126.8% from -$398.5 to $106.8, and net income increased 119.01% from -$423.4 to $80.5.
Fuse Medical, Inc. (FZMD) was upgraded to D from D- on 11/18/2020 due to a significant increase in the growth index, efficiency index and solvency index. Operating cash flow increased 258.5% from $117.6 to $421.6, EBIT increased 126.8% from -$398.5 to $106.8, and net income increased 119.01% from -$423.4 to $80.5.
D
Sell
6/9/2020Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to D- from D on 6/9/2020 due to a noticeable decline in the growth index, total return index and solvency index. EBIT declined 383.83% from $439.8 to -$1.25M, earnings per share declined from $0.0172 to -$0.0183, and operating cash flow declined 191.25% from $83.4 to -$76.1.
Fuse Medical, Inc. (FZMD) was downgraded to D- from D on 6/9/2020 due to a noticeable decline in the growth index, total return index and solvency index. EBIT declined 383.83% from $439.8 to -$1.25M, earnings per share declined from $0.0172 to -$0.0183, and operating cash flow declined 191.25% from $83.4 to -$76.1.
D
Sell
5/1/2020Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D from D- on 5/1/2020 due to a major increase in the efficiency index, total return index and volatility index. Total capital increased 179.04% from -$860.8 to $680.4, and net income increased 134.47% from -$4.06M to $1.4M.
Fuse Medical, Inc. (FZMD) was upgraded to D from D- on 5/1/2020 due to a major increase in the efficiency index, total return index and volatility index. Total capital increased 179.04% from -$860.8 to $680.4, and net income increased 134.47% from -$4.06M to $1.4M.
D
Sell
11/15/2019Downgrade
Fuse Medical, Inc. (FZMD) was downgraded to D- from D+ on 11/15/2019 due to a significant decline in the efficiency index, valuation index and growth index. Earnings per share declined from -$0.002 to -$0.0579, net income declined 2,760.17% from -$142.1 to -$4.06M, and EBIT declined 1,908.35% from -$154.5 to -$3.1M.
Fuse Medical, Inc. (FZMD) was downgraded to D- from D+ on 11/15/2019 due to a significant decline in the efficiency index, valuation index and growth index. Earnings per share declined from -$0.002 to -$0.0579, net income declined 2,760.17% from -$142.1 to -$4.06M, and EBIT declined 1,908.35% from -$154.5 to -$3.1M.
D
Sell
8/1/2019Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D+ from D on 8/1/2019 due to a significant increase in the valuation index, growth index and total return index. Operating cash flow increased 119.19% from -$458.6 to $88.
Fuse Medical, Inc. (FZMD) was upgraded to D+ from D on 8/1/2019 due to a significant increase in the valuation index, growth index and total return index. Operating cash flow increased 119.19% from -$458.6 to $88.
D
Sell
2/1/2019Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D from D- on 2/1/2019 due to an increase in the solvency index and growth index. EBIT increased 120.07% from -$1.96M to $394.1, earnings per share increased from -$0.04 to $0.0049, and operating cash flow increased 28.86% from $963 to $1.24M.
Fuse Medical, Inc. (FZMD) was upgraded to D from D- on 2/1/2019 due to an increase in the solvency index and growth index. EBIT increased 120.07% from -$1.96M to $394.1, earnings per share increased from -$0.04 to $0.0049, and operating cash flow increased 28.86% from $963 to $1.24M.
D
Sell
10/1/2018Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to D- from E on 10/1/2018 due to an increase in the valuation index and efficiency index.
Fuse Medical, Inc. (FZMD) was upgraded to D- from E on 10/1/2018 due to an increase in the valuation index and efficiency index.
E
Sell
7/2/2018Upgraded
Fuse Medical, Inc. (FZMD) was upgraded to E from E- on 07/02/2018.
Fuse Medical, Inc. (FZMD) was upgraded to E from E- on 07/02/2018.
E
Sell
5/16/2018None
Fuse Medical, Inc. (FZMD) was downgraded to E- from U on 05/16/2018.
Fuse Medical, Inc. (FZMD) was downgraded to E- from U on 05/16/2018.
OTC PK
04/01/2025 12:18PM Eastern
Quotes delayed
